+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Immunotherapy in Translational Cancer Research. Edition No. 1. Translational Oncology

  • ID: 4454873
  • Book
  • April 2018
  • 312 Pages
  • John Wiley and Sons Ltd

A guide to state-of-the-art cancer immunotherapy in translational cancer research 

A volume in the Translational Oncology series, Immunotherapy in Translational Cancer Research explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, Immunotherapy in Translational Cancer Research reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues.

Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world’s foremost cancer research and care center and: 

  • Offers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care 
  • Filled with the concepts, examples, and approaches for developing individualized therapy
  • Explores the breath of treatments that reflect the complexity of the immune system itself
  • Includes contributions from a panel international experts in the field of immunotherapy

Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research.

Note: Product cover images may vary from those shown

Editors vi

Contributors vii

Introduction ix

1 Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer 1
Saranya Chumsri and Keith L. Knutson

2 Monoclonal Antibody Therapy 12
Elizabeth A. Mittendorf and Sabitha Prabhakaran

3 Somatic Mutations and Immunotherapy 24
Eric Tran

4 Checkpoint Blockade 37
Tracy A. Proverbs‐Singh Jedd Wolchok and Alexandra Snyder

5 Myeloid Leukemia Vaccines 54
Paul M. Armistead and Jonathan S. Serody

6 Cancer Vaccines for Solid Tumors 72
Timothy J. Vreeland Garth S. Herbert and George E. Peoples

7 Immunotherapy with Non–Genetically Modified T Cells 91
Cassian Yee

8 Immunotherapy with Genetically Modified T Cells 101
Liora Schultz and Crystal Mackall

9 Immunomodulation with Adjuvants and Cytokines 115
Dae won Kim and Adi Diab

10 Immune Cell Migration in Cancer and Immunotherapy 132
Timothy Murray and Daniel E. Speiser

11 Repurposing of Drugs for Immunotherapy 143
Jyothishmathi Swaminathan and Vidya Gopalakrishnan

12 Immunomodulation with Radiation 161
Jonathan E. Schoenhals Taylor R. Cushman, Alexandra P. Cadena Sandra Demaria and James W. Welsh

13 Good Manufacturing Practices Facilities for Cellular Therapy 177
Andrew D. Fesnak and Bruce L. Levine

14 T Cell Receptor Mimic Antibodies 186
Gheath Alatrash and Jeffrey J. Molldrem

15 Stem Cell Transplantation for Treatment of Malignancy 201
Lohith S. Bachegowda and Richard E. Champlin

16 Natural Killer Cell–Based Immunotherapy 215
Jennifer A. Foltz Jeffrey S. Miller and Dean A. Lee

17 Immunologic Monitoring in Immuno‐Oncology 228
William R. Gwin and Mary L. Disis

18 Cell‐Based Therapies for Canine Cancer 252
Nicola J. Mason and M. Kazim Panjwani

19 Interaction between Targeted Therapy and Immunotherapy 268
Peter A. Prieto Miles C. Andrews, Alexandria P. Cogdill, and Jennifer A. Wargo

Index 286

Note: Product cover images may vary from those shown
Laurence J. N. Cooper Associate Professor, Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Elizabeth A. Mittendorf Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Judy Moyes Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sabitha Prabhakaran Clinical Research Scientist, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Note: Product cover images may vary from those shown